- Revenue: not reported for QQ2 2024 (N/A). - Operating income: -236,140 USD; YoY improvement cited as 65.39% with QoQ change of -1.39%. - Net income: -141,242 USD; YoY improvement cited as 79.01% with QoQ change of 36.21%. - EPS: -0.0019 USD; YoY improvement 81.00% with QoQ 36.67%. - EBITDA: -236,135 USD; - Operating cash flow: -139,994 USD; Free cash flow: -139,994 USD. - Cash and cash equivalents: 764,493 USD at period end; total assets: 1,229,810 USD; total stockholdersβ equity: 1,188,696 USD; no debt reported. - Liquidity metrics: current ratio 19.80; cash ratio 18.59; quick ratio 19.80. - Balance sheet health indicates a large accumulated deficit (retained earnings: -42,706,675 USD) despite a solid cash cushion, suggesting substantial accumulated losses prior to QQ2 2024.